Indaptus Therapeutics shows positive financial results for Q1 2024, progressing in clinical development.
From GlobeNewswire: 2024-05-08 08:00:00 Indaptus Therapeutics, a biotechnology company, shared financial results for the first quarter of 2024. They continue
